Suven Pharmaceuticals informs about loss of share certificate

18 Mar 2023 Evaluate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Pharmaceuticals has informed that the Company has received intimation from shareholder of the Company, regarding loss of share certificate(s) as details enclosed. An email request received from Shareholder is enclosed. The Company is in process of issuing ‘Letter of Confirmation’ in lieu of the original share certificate(s), after completion of required formalities.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

537.60 1.85 (0.35%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×